To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

Clinical trial NCT00353366 · COMPLETED

Trial details

NCT number: NCT00353366
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Infections, Rotavirus Rotavirus Vaccines

Start date: 2006-11-16
Primary completion: 2010-03-31
Enrollment: 1439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.